Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Endologix, Inc. (NASDAQ: ELGX).

Full DD Report for ELGX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ELGX)

Looking Beyond The Election (Stocks To Watch Podcast)
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f...
Source: SeekingAlpha
Date: November, 04 2018 06:30
Stocks To Watch: Looking Beyond The Election
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Yep, there is an election next week that's going to steal some headlines, but inves...
Source: SeekingAlpha
Date: November, 03 2018 09:26
Endologix Inc. (ELGX) CEO John Onopchenko on Q3 2018 Results - Earnings Call Transcript
Endologix Inc. (ELGX) Q3 2018 Earnings Conference Call November 01, 2018 4:30 PM ET Executives John Onopchenko – Chief Executive Officer Vaseem Mahboob – Chief Financial Officer Matt Thompson – Chief Medical Officer Analysts Matthew Blackman – St...
Source: SeekingAlpha
Date: November, 02 2018 20:06
Endologix beats by $0.18, beats on revenue
Endologix (NASDAQ: ELGX ): Q3 GAAP EPS of -$0.12 beats by $0.18 . More news on: Endologix Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 01 2018 16:10
Endologix Reports Third Quarter 2018 Financial Results
Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the third quarter ended September 30, 2018. “While there is still significant work to be done, our third...
Source: Business Wire
Date: November, 01 2018 16:01
Notable earnings after Thursday's close
AAPL , ACIA , ACLS , AIRG , AIV , ALEX , AMH , ANET , AOSL , APPN , ARCB , ATGE , ATHN , ATR , ATRC , ATSG , BCOV , BFAM , BIO , BL , BLDR , BNFT , BRKR , BVX , CARB , CATM , CBPO , CBS , CC , CCRN , CECO , CERS , CHEF , CNMD , CNXN , CORT , CPS , CPSI ...
Source: SeekingAlpha
Date: October, 31 2018 17:35
Endologix, Inc. to Present at Two Investor Conferences in November
Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will present at the following two investor conferences in November: Conference: Stephens NY Investment Conference Location: New York, NY Date: Tuesday, November ...
Source: Business Wire
Date: October, 29 2018 16:01
Endologix Announces Pricing of Public Offering of Common Stock
Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), developer and marketer of innovative treatments for aortic disorders, announced today the pricing of a registered underwritten public offering of its common stock for net proceeds of $20.0 million, bef...
Source: Business Wire
Date: October, 25 2018 10:16
Earnings misses and weak guidance lead stocks lower premarket
AMD   -20%  on  Q3 earnings . More news on: Advanced Micro Devices, Inc., Align Technology, Inc., WPP Plc, Stocks on the move, Top stock market news, , Read more ...
Source: SeekingAlpha
Date: October, 25 2018 09:23
New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI), Arrowhead Pharma...
Source: GlobeNewswire
Date: August, 28 2018 08:10

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-082.342.202.392.141,187,702
2018-05-175.064.955.154.86394,485
2017-02-036.876.926.966.75528,361
2017-02-026.926.857.0356.831,515,260
2017-02-016.907.017.146.762,005,396

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1446,514312,50014.8845Cover
2018-12-1337,430107,76334.7336Cover
2018-12-12111,887374,24329.8969Cover
2018-12-1141,921332,96912.5901Cover
2018-12-1021,442114,91718.6587Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ELGX.


About Endologix, Inc. (NASDAQ: ELGX)

Logo for Endologix, Inc. (NASDAQ: ELGX)

Not available

 

Contact Information

 

 

Current Management

  • Jeffrey H. Thiel / President, CEO
  • Robert J. Krist / CFO

Current Share Structure

  • Market Cap: $407,741,709 - 05/15/2018
  • Issue and Outstanding: 83,725,197 - 03/12/2018

 


Recent Filings from (NASDAQ: ELGX)

Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 17 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Information for Proxy Statement under Rule 14a-101
Filing Type: DEFR14AFiling Source: edgar
Filing Date: April, 30 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 20 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 17 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 13 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: March, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 21 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: ELGX)

Daily Technical Chart for (NASDAQ: ELGX)


Stay tuned for daily updates and more on (NASDAQ: ELGX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ELGX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ELGX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ELGX and does not buy, sell, or trade any shares of ELGX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/